FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product

December 23, 2021

Biotricity to Host Third Quarter Fiscal Year 2024 Financial Results and Business Update Call on February 21st

February 19, 2024
Endexx Corporation Announces Strategic Shift in Auditor Services to Bolster Growth and Transparency

February 16, 2024
Biotricity Advances Towards Breakeven Milestone – Set to Announce Record Margins and Operational Efficiency for Third Quarter of Fiscal Year 2024

February 14, 2024
Petros Pharmaceuticals Enters into AI Licensing Agreement with Leading Multi-Billion-Dollar Software Provider

February 14, 2024